Concepedia

Taichi Kuramochi

TK

15

Publications

647

Citations

13

H-Index

1997

Active since

Affiliations

Chugai Pharma (United States)(Current)

Taichi Kuramochi is an author at Chugai Pharma (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1997–2023

15

Publications

15

Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIaR131 and FcγRIIaH131

Futa Mimoto, Hitoshi Katada, Shojiro Kadono et al. · Protein Engineering Design and Selection · 2013 · 127 citations · Full text

Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A

Atsushi Muto, Kazutaka Yoshihashi, Minako Takeda et al. · Blood · 2014 · 92 citations · Full text

Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant

Futa Mimoto, Tomoyuki Igawa, Taichi Kuramochi et al. · mAbs · 2013 · 71 citations · Full text

Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody

Zenjiro Sampei, Kenta Haraya, Tatsuhiko Tachibana et al. · PLoS ONE · 2018 · 56 citations · Full text

Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Sohei Oyama, Hidetomo Kitamura, Taichi Kuramochi et al. · Experimental Dermatology · 2016 · 54 citations · Full text

Rows per page

1–5 of 15